Correction: Development of oligonucleotide-based antagonists of Ebola virus protein 24 inhibiting its interaction
Keisuke Tanaka1, Yuuya Kasahara, Yoichi Miyamoto
1Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
Abstract:
Correction for 'Development of oligonucleotide-based antagonists of Ebola virus protein 24 inhibiting its interaction with karyopherin alpha 1' by Keisuke Tanaka et al., Org. Biomol. Chem., 2018, 16, 4456-4463.
More Related Videos
09:45An Oligonucleotide-based Tandem RNA Isolation Procedure to Recover Eukaryotic mRNA-Protein Complexes
Published on: August 18, 2018
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Piaget's Stage 1 of Cognitive Development
Exploration...
Distance Corrections
Feedback Inhibition
What are Viruses?
